Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy

Current Controlled Trials in Cardiovascular Medicine

Volumn 1, Issue 2, 2000, Pages 115-119

  Seggewiss, H ^a  

^a Leopoldina Krankenhaus   (Germany)

Author keywords

Hypertrophic obstructive cardiomyopathy; Percutaneous septal ablation; Remodeling

Indexed keywords

ALCOHOL; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CIBENZOLINE; DISOPYRAMIDE; VERAPAMIL;

ANTICHOLINERGIC EFFECT; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; CATHETER ABLATION; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MUSCLE RESECTION; OCCLUSION; PROPHYLAXIS; REVIEW; SIDE EFFECT; SYMPTOM;

EID: 0034467612     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-1-2-115     Document Type: Review

References (36)

1. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
2. The management of hypertrophic cardiomyopathy
3. Sudden death from cardiac causes in children and young adults
4. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: Too soon for a rush to judgment?
5. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy
6. Treatment of hypertrophic obstructive cardiomyopathy with verapamil
7. Long-term follow-up of medical vs surgical therapy for hypertrophic cardiomyopathy: A retrospective study
8. Verapamil: Its potential for causing serious complication in patients with hypertrophic cardiomyopathy
9. Effects of beta adrenergic blockade on the circulation with particular reference to patients with hypertrophic subaortic stenosis
10. Muscular subaortic stenosis: Prevention of outflow obstruction with propanolol
11. Effects of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy
12. Muscular subaortic stenosis: Hemodynamic and clinical improvement after disopyramide
13. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
14. Class Ia antiarrhythmic drug cibenzoline: A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy
15. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
16. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
17. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy
18. Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis
19. Hypertrophe obstruktive kardiomyopathie: Chirurgische behandlung
20. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
21. Surgical management of hypertrophic obstructive cardiomyopathy: Early and late results
22. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus
23. Transcoronary chemical ablation of ventricular tachycardia
24. Percutaneous transluminal septal myocardardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
25. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute and 3-months follow-up results with respect to myocardial contrast echocardiography
26. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area
27. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
28. Improvement of acute results after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy during mid-term follow-up
29. Acute and long-term results after transcoronary ablation of septum hypertrophy in hypertrophic obstructive cardiomyopathy
30. Non-surgical septal ablation (PTSMA) in patients with NYHA class IV and hypertrophic obstructive cardiomyopathy (HOCM)
31. Age-related acute results in percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
32. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long term follow up of the first series of 25 patients
33. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
34. Percutaneous septal ablation in patients with hypertrophic obstructive cardiomyopathy results in improvement of exercise capacity
35. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
36. Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment